Hydrochloric acid salt of a 5-ht2c agonist

TW202629150APending Publication Date: 2026-07-16ARENA PHARMACEUTICALS INC

Patent Information

Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
ARENA PHARMACEUTICALS INC
Filing Date
2025-09-30
Publication Date
2026-07-16

Smart Images

  • Figure 00000000_0000_ABST
    Figure 00000000_0000_ABST
Patent Text Reader

Abstract

A crystalline (R)-N-(2,2-difluoroethyl)-7-methyl-1,2,3,4,6,7-hexahydro-[1,4]diazapolo[6,7,1-hi]indole-8-methamide (compound 1) hydrochloric acid (HCl) salt is provided. Pharmaceutical compositions comprising this salt and methods of use thereof are also provided. Provided is crystalline (R)-N-(2,2-difluoroethyl)-7-methyl-l,2,3,4,6,7-hexahydro-[l,4]diazepino[6,7,l-hi]indole-8-carboxamide (Compound 1) hydrochloric acid (HCl) salt. Also provided pharmaceutical compositions comprising the salt form and methods for its use.
Need to check novelty before this filing date? Find Prior Art